These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7427885)

  • 1. The prognostic value of HLA phenotypes in Hodgkin's disease.
    Osoba D; Falk JA; Sousan P; Ciampi A; Till JE
    Cancer; 1980 Oct; 46(8):1825-32. PubMed ID: 7427885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of HLA phenotypes in the prognosis of Hodgkin's lymphoma.
    Hafez MM; el-Wehedy GF; el-Kholy NM; el-Shawaf IM; Mahmoud ME; Gamil TM
    Int J Cancer; 1985 Jul; 36(1):19-22. PubMed ID: 4018904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation of HLA antigens to prognosis in Hodgkin's disease].
    Prazák J; Chytrý P; Hermanská Z
    Vnitr Lek; 1991; 37(9-10):781-8. PubMed ID: 1771812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.
    Chakravarti A; Halloran SL; Bale SJ; Tucker MA
    Genet Epidemiol; 1986; 3(6):407-15. PubMed ID: 3803911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Hodgkin's disease in three siblings with identical HLA-genotype.
    Torres A; Martinez F; Gómez P; Gómez C; Garcia JM; Nuñez-Roldan A
    Cancer; 1980 Aug; 46(4):838-43. PubMed ID: 7397649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
    Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
    Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
    Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HLA system in acute leukaemia and Hodgkin's disease.
    Harris R; Lawler SD; Oliver RT
    Br Med Bull; 1978 Sep; 34(3):301-4. PubMed ID: 363226
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA genotypes in familial Hodgkin's disease. Excess of HLA identical affected subs.
    Hors J; Steinberg G; Andrieu JM; Jacquillat C; Minev M; Messerschmitt J; Malinvaud G; Fumeron F; Dausset J; Bernard J
    Eur J Cancer (1965); 1980 Jun; 16(6):809-15. PubMed ID: 7408930
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA and MLC typing in patients with Hodgkin's disease.
    Hansen JA; Young CW; Whitsett C; Case DC; Jersild C; Good RA; Dupont B
    Prog Clin Biol Res; 1977; 16():217-27. PubMed ID: 143667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigens in Hodgkin's disease of very long survival.
    Hornmark-Stenstam B; Landberg T; Löw B
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(4):283-8. PubMed ID: 717041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA in familial Hodgkin's disease.
    Conte R; Lauria F; Zucchelli P
    J Immunogenet; 1983 Jun; 10(3):251-5. PubMed ID: 6875280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of prognostic factors in early stage Hodgkin's disease.
    Horwich A; Easton D; Nogueira-Costa R; Liew KH; Colman M; Peckham MJ
    Radiother Oncol; 1986 Oct; 7(2):95-106. PubMed ID: 3786824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method.
    Berberich FR; Berberich MS; King MC; Engleman EG; Grumet FC
    Hum Immunol; 1983 Apr; 6(4):207-17. PubMed ID: 6221004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between sex and HLA type in Hodgkin's disease.
    Grufferman S; Cole P
    Arch Neurol; 1984 Aug; 41(8):816. PubMed ID: 6466155
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA antigens in familial Hodgkin's disease.
    Greene MH; McKeen EA; Li FP; Blattner WA; Fraumeni JF
    Int J Cancer; 1979 Jun; 23(6):777-80. PubMed ID: 468411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the prognostic significance of serum immunoglobulins in Hodgkin's disease].
    Usnarska-Zubkiewicz L; Gola A; Gabryś K; Niewolna M
    Pol Arch Med Wewn; 1991 Jan; 85(1):50-8. PubMed ID: 2038576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.